Holen Sie sich die Stockscreener-App
43.66
12.12%
4.72
Schlusskurs vom Vortag:
$38.94
Offen:
$38.68
24-Stunden-Volumen:
270.15K
Relative Volume:
0.95
Marktkapitalisierung:
$1.95B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+18.00%
1M Leistung:
+2.73%
6M Leistung:
+223.41%
1J Leistung:
+0.00%
1-Tages-Spanne:
$38.68
$43.93
1-Wochen-Bereich:
$36.81
$43.93
52-Wochen-Spanne:
$7.255
$43.93
Sionna Therapeutics Inc Stock (SION) Company Profile
Firmenname
Sionna Therapeutics Inc
Sektor
Branche
Telefon
617-819-2020
Adresse
21 HICKORY DRIVE, SUITE 500, WALTHAM
Vergleichen Sie SION mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
43.66 | 1.74B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-19 | Eingeleitet | BTIG Research | Buy |
| 2025-09-03 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-03-04 | Eingeleitet | Guggenheim | Buy |
| 2025-03-04 | Eingeleitet | Stifel | Buy |
| 2025-03-04 | Eingeleitet | TD Cowen | Buy |
Alle ansehen
Sionna Therapeutics Inc Aktie (SION) Neueste Nachrichten
Is Sionna Therapeutics Inc. stock a smart buy before Fed meetingGap Down & High Yield Equity Trading Tips - newser.com
Will Sionna Therapeutics Inc. stock reach Wall Street targetsMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m By Investing.com - Investing.com Canada
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m - Investing.com
[Form 4] Sionna Therapeutics, Inc. Insider Trading Activity - Stock Titan
Owner RA Capital Management LP Sells 136,351 ($5.5M) Of Sionna Therapeutics Inc [SION] - TradingView
Is Sionna Therapeutics Inc. stock a safe buy before earningsTrade Risk Report & Risk Controlled Daily Plans - newser.com
Owner RA Capital Healthcare Fund LP Files To Sell 2,278 Of Sionna Therapeutics Inc [SION] - TradingView
How Sionna Therapeutics Inc. stock performs in rising dollar environmentMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
What Fibonacci levels say about Sionna Therapeutics Inc. reboundJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
What Wall Street predicts for Sionna Therapeutics Inc. stock price2025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com
Will Sionna Therapeutics Inc. stock go up soonJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
BTIG Research Initiates Coverage on Sionna Therapeutics With Buy Rating, $50 Price Target - MarketScreener
BTIG Initiates Coverage of Sionna Therapeutics (SION) with Buy Recommendation - Nasdaq
How analysts rate Sionna Therapeutics Inc. stock todayQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential - TipRanks
Is Sionna Therapeutics Inc. stock a safe haven assetJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy - MSN
Relative strength of Sionna Therapeutics Inc. in sector analysisQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
Sionna Therapeutics Inc. stock trendline breakdownJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Will Sionna Therapeutics Inc. rebound enough to break evenWeekly Profit Summary & Stepwise Trade Execution Plans - newser.com
Why Sionna Therapeutics Inc. stock attracts global investorsBear Alert & Safe Entry Point Identification - newser.com
Is Moongipa Capital Finance Limited a Top Alpha Generator for Growth PortfoliosStock Screening Results & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Is Sionna Therapeutics Inc a good long term investmentSell Signals and Alerts & Double Digit Capital Growth - earlytimes.in
Finanzdaten der Sionna Therapeutics Inc-Aktie (SION)
Es liegen keine Finanzdaten für Sionna Therapeutics Inc (SION) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):